INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $138,000 | +3.0% | 13,683 | -26.0% | 0.00% | – |
| Q2 2018 | $134,000 | +21.8% | 18,483 | +1.4% | 0.00% | – |
| Q1 2018 | $110,000 | -63.1% | 18,233 | -41.2% | 0.00% | -100.0% |
| Q4 2017 | $298,000 | +109.9% | 31,008 | +93.5% | 0.00% | – |
| Q3 2017 | $142,000 | -6.6% | 16,026 | +33.5% | 0.00% | – |
| Q2 2017 | $152,000 | +6.3% | 12,002 | -0.9% | 0.00% | – |
| Q3 2016 | $143,000 | -61.9% | 12,116 | -8.1% | 0.00% | -100.0% |
| Q3 2015 | $375,000 | -29.6% | 13,184 | -11.1% | 0.00% | 0.0% |
| Q2 2015 | $533,000 | -15.8% | 14,831 | +36.1% | 0.00% | -33.3% |
| Q1 2015 | $633,000 | -37.1% | 10,896 | -58.0% | 0.00% | -50.0% |
| Q3 2014 | $1,006,000 | +62.0% | 25,940 | +30.5% | 0.01% | +50.0% |
| Q2 2014 | $621,000 | – | 19,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |